UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Monoamine neurotransmitter disorders-clinical advances and future perspectives

Ng, J; Papandreou, A; Heales, SJ; Kurian, MA; (2015) Monoamine neurotransmitter disorders-clinical advances and future perspectives. Nature Reviews Neurology , 11 (10) pp. 567-584. 10.1038/nrneurol.2015.172.

Full text not available from this repository.

Abstract

The monoamine neurotransmitter disorders are important genetic syndromes that cause disturbances in catecholamine (dopamine, noradrenaline and adrenaline) and serotonin homeostasis. These disorders result in aberrant monoamine synthesis, metabolism and transport. The clinical phenotypes are predominantly neurological, and symptoms resemble other childhood neurological disorders, such as dystonic or dyskinetic cerebral palsy, hypoxic ischaemic encephalopathy and movement disorders. As a consequence, monoamine neurotransmitter disorders are under-recognized and often misdiagnosed. The diagnosis of monoamine neurotransmitter disorders requires detailed clinical assessment, cerebrospinal fluid neurotransmitter analysis and further supportive diagnostic investigations. Prompt and accurate diagnosis of neurotransmitter disorders is paramount, as many are responsive to treatment. The treatment is usually mechanism-based, with the aim to reverse disturbances of monoamine synthesis and/or metabolism. Therapeutic intervention can lead to complete resolution of motor symptoms in some conditions, and considerably improve quality of life in others. In this Review, we discuss the clinical features, diagnosis and management of monoamine neurotransmitter disorders, and consider novel concepts, the latest advances in research and future prospects for therapy.

Type: Article
Title: Monoamine neurotransmitter disorders-clinical advances and future perspectives
DOI: 10.1038/nrneurol.2015.172
Publisher version: http://dx.doi.org/10.1038/nrneurol.2015.172
Language: English
Keywords: Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Neurosciences & Neurology, Amino-Acid Decarboxylase, Tyrosine-Hydroxylase Deficiency, Dopa-Responsive Dystonia, Sepiapterin Reductase Deficiency, Gtp-Cyclohydrolase-I, Central-Nervous-System, Aicardi-Goutieres-Syndrome, 6-Pyruvoyl-Tetrahydropterin Synthase Deficiency, 6-Pyruvoyl Tetrahydropterin Synthase, Pyridoxine-Dependent Epilepsy
UCL classification: UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Women's Health > Maternal and Fetal Medicine
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Child Health
?? ICH5 ??
URI: http://discovery.ucl.ac.uk/id/eprint/1551652
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item